Clinical Trials
4 trialsNCT03415802 2021-02-01
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
ChineseAMS
Phase 2 Completed
NCT01980810 2016-06-14
GC-A-003
ChineseAMS
Phase 2 Terminated
NCT01969955 2014-04-25
Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer
ChineseAMS
Phase 2 Unknown
NCT01667211 2012-08-22
CSAPPPCC
ChineseAMS
Phase 2 Unknown